<?xml version="1.0" encoding="UTF-8"?>
<p>After initial coronavirus infection, immune responses appear effective in controlling viral infection, suggesting that vaccines should be feasible. There were important caveats from animal vaccine models: antibody responses waned quickly, indicating that immune responses might not be long-lasting.
 <sup>
  <xref rid="R18" ref-type="bibr">18</xref>
 </sup> Also, in one mouse coronavirus model of SARS, natural killer cell, antibody, and interferon responses were beneficial, but T-cell responses paradoxically worsened outcomes.
 <sup>
  <xref rid="R19" ref-type="bibr">19</xref>
 </sup> Accordingly, vaccines will need to demonstrate safety and effectiveness before widespread adoption.
</p>
